Patent Grant USPTO April 2019

Welcome to

CHORD Therapeutics

Drug development for rare neurological diseases


Geneva, 25 April 2019:


The USPTO has issued a Notice of Allowance for Chord Therapeutics' key patent application, titled "Use of Cladribine for Treatment of Inflammatory Neurological Disease".